PROF Financial Statements

Balance sheet, income statement, cash flow, and dividends for Profound Medical Corp (PROF).


$185.21M Market Cap.

As of 03/07/2025 5:00 PM ET (MRY) • Disclaimer

PROF Market Cap. (MRY)


PROF Shares Outstanding (MRY)


PROF Assets (MRY)


Total Assets

$70.23M

Total Liabilities

$9.81M

Total Investments

$0

PROF Income (MRY)


Revenue

$10.68M

Net Income

-$27.82M

Operating Expense

$40.10M

PROF Cash Flow (MRY)


CF Operations

-$23.45M

CF Investing

$0

CF Financing

$54.70M

PROF Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PROF Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$70,234,000 (59.95%)

$43,911,000 (-31.84%)

$64,421,000 (-25.76%)

$86,775,000 (-17.04%)

Assets Current

$69,065,000 (64.85%)

$41,896,000 (-32.45%)

$62,024,000 (-19.58%)

$77,125,000 (-21.09%)

Assets Non-Current

$1,169,000 (-41.99%)

$2,015,000 (-15.94%)

$2,397,000 (-75.16%)

$9,650,000 (40.69%)

Goodwill & Intangible Assets

$261,000 (-46.73%)

$490,000 (-27.94%)

$680,000 (-83.51%)

$4,124,000 (-9.88%)

Shareholders Equity

$60,422,000 (93.78%)

$31,180,000 (-40.04%)

$52,004,000 (-35.49%)

$80,618,000 (-17.19%)

Property Plant & Equipment Net

$821,000 (-46.16%)

$1,525,000 (-11.18%)

$1,717,000 (-9.82%)

$1,904,000 (-16.60%)

Cash & Equivalents

$54,912,000 (109.48%)

$26,213,000 (-43.65%)

$46,517,000 (-30.73%)

$67,152,000 (-19.97%)

Accumulated Other Comprehensive Income

$2,742,000 (-77.21%)

$12,031,000 (-28.54%)

$16,837,000 (254.76%)

$4,746,000 (3.92%)

Deferred Revenue

$468,000 (-67.70%)

$1,449,000 (17.33%)

$1,235,000 (-8.65%)

$1,352,000 (-5.85%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$5,801,000 (-17.00%)

$6,989,000 (-11.99%)

$7,941,000 (7.12%)

$7,413,000 (39.05%)

Trade & Non-Trade Receivables

$7,045,000 (-3.33%)

$7,288,000 (14.88%)

$6,344,000 (26.02%)

$5,034,000 (-32.26%)

Trade & Non-Trade Payables

$1,317,000 (-59.87%)

$3,282,000 (56.96%)

$2,091,000 (-34.25%)

$3,180,000 (-5.97%)

Accumulated Retained Earnings (Deficit)

-$245,170,000 (-12.50%)

-$217,931,000 (-15.09%)

-$189,362,000 (-17.84%)

-$160,693,000 (-23.62%)

Tax Assets

$87,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$298,000 (0%)

$0 (0%)

Total Debt

$5,121,000 (-35.51%)

$7,941,000 (-3.51%)

$8,230,000 (497.68%)

$1,377,000 (-17.84%)

Debt Current

$1,994,000 (-15.62%)

$2,363,000 (210.10%)

$762,000 (204.80%)

$250,000 (-19.87%)

Debt Non-Current

$3,127,000 (-43.94%)

$5,578,000 (-25.31%)

$7,468,000 (562.64%)

$1,127,000 (-17.38%)

Total Liabilities

$9,812,000 (-22.93%)

$12,731,000 (2.53%)

$12,417,000 (101.67%)

$6,157,000 (-15.09%)

Liabilities Current

$6,565,000 (3.13%)

$6,366,000 (52.11%)

$4,185,000 (0.72%)

$4,155,000 (-13.60%)

Liabilities Non-Current

$3,247,000 (-48.99%)

$6,365,000 (-22.68%)

$8,232,000 (311.19%)

$2,002,000 (-18.02%)

PROF Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$10,680,000 (48.35%)

$7,199,000 (7.75%)

$6,681,000 (-2.79%)

$6,873,000 (-5.90%)

Cost of Revenue

$3,643,000 (29.32%)

$2,817,000 (-23.03%)

$3,660,000 (-6.66%)

$3,921,000 (2.38%)

Selling General & Administrative Expense

$23,134,000 (24.24%)

$18,621,000 (3.84%)

$17,933,000 (-0.18%)

$17,966,000 (44.60%)

Research & Development Expense

$16,965,000 (18.00%)

$14,377,000 (-2.13%)

$14,690,000 (-3.84%)

$15,277,000 (54.13%)

Operating Expenses

$40,099,000 (21.52%)

$32,998,000 (-6.11%)

$35,147,000 (5.73%)

$33,243,000 (48.82%)

Interest Expense

$0 (0%)

$81,000 (102.16%)

-$3,744,000 (-1335.64%)

$303,000 (-88.84%)

Income Tax Expense

-$2,000 (98.44%)

-$128,000 (-144.60%)

$287,000 (173.33%)

$105,000 (133.33%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$27,816,000 (2.64%)

-$28,569,000 (0.35%)

-$28,669,000 (6.61%)

-$30,699,000 (-41.98%)

Net Income to Non-Controlling Interests

$0 (0%)

$4,806,000 (139.75%)

-$12,091,000 (-6654.75%)

-$179,000 (-106.39%)

Net Income

-$27,816,000 (16.66%)

-$33,375,000 (-101.32%)

-$16,578,000 (45.68%)

-$30,520,000 (-24.96%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$27,816,000 (16.66%)

-$33,375,000 (-101.32%)

-$16,578,000 (45.68%)

-$30,520,000 (-24.96%)

Weighted Average Shares

$24,765,503 (15.91%)

$21,365,733 (2.35%)

$20,876,027 (0.51%)

$20,769,251 (5.83%)

Weighted Average Shares Diluted

$24,765,503

-

-

-

Earning Before Interest & Taxes (EBIT)

-$27,818,000 (16.77%)

-$33,422,000 (-66.82%)

-$20,035,000 (33.47%)

-$30,112,000 (-38.99%)

Gross Profit

$7,037,000 (60.59%)

$4,382,000 (45.05%)

$3,021,000 (2.34%)

$2,952,000 (-15.03%)

Operating Income

-$33,062,000 (-15.54%)

-$28,616,000 (10.93%)

-$32,126,000 (-6.06%)

-$30,291,000 (-60.58%)

PROF Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

-$593,000 (-69.43%)

Net Cash Flow from Financing

$54,696,000 (3636.07%)

$1,464,000 (-79.18%)

$7,031,000 (18.21%)

$5,948,000 (-93.20%)

Net Cash Flow from Operations

-$23,453,000 (-5.18%)

-$22,297,000 (13.58%)

-$25,800,000 (-15.38%)

-$22,360,000 (-8.68%)

Net Cash Flow / Change in Cash & Cash Equivalents

$31,243,000 (249.97%)

-$20,833,000 (-11.00%)

-$18,769,000 (-10.37%)

-$17,005,000 (-125.57%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

-$32,000 (0%)

Issuance (Repayment) of Debt Securities

-$7,455,000 (-519.19%)

-$1,204,000 (-117.79%)

$6,768,000 (1853.37%)

-$386,000 (95.98%)

Issuance (Purchase) of Equity Shares

$45,000 (-98.31%)

$2,668,000 (914.45%)

$263,000 (-95.91%)

$6,433,000 (-93.80%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$2,544,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,581,000 (-24.47%)

$3,417,000 (-19.37%)

$4,238,000 (-41.18%)

$7,205,000 (138.73%)

Depreciation Amortization & Accretion

$936,000 (-18.32%)

$1,146,000 (-28.55%)

$1,604,000 (-14.64%)

$1,879,000 (22.17%)

PROF Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

65.90% (8.21%)

60.90% (34.73%)

45.20% (5.12%)

43.00% (-9.66%)

Profit Margin

-260.40% (43.83%)

-463.60% (-86.86%)

-248.10% (44.13%)

-444.10% (-32.81%)

EBITDA Margin

-251.70% (43.85%)

-448.30% (-62.49%)

-275.90% (32.84%)

-410.80% (-49.06%)

Return on Average Equity (ROAE)

-63.00% (23.17%)

-82.00% (-214.18%)

-26.10% (24.78%)

-34.70% (-29.96%)

Return on Average Assets (ROAA)

-50.60% (19.55%)

-62.90% (-167.66%)

-23.50% (27.69%)

-32.50% (-31.58%)

Return on Sales (ROS)

-260.50% (43.89%)

-464.30% (-54.82%)

-299.90% (31.55%)

-438.10% (-47.71%)

Return on Invested Capital (ROIC)

-194.20% (-6.41%)

-182.50% (-40.28%)

-130.10% (38.31%)

-210.90% (-24.72%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-9.66 (-15.45%)

-8.36 (22.63%)

-10.81 (-12.81%)

-9.58 (54.30%)

Price to Sales Ratio (P/S)

25.08 (-25.17%)

33.51 (-28.11%)

46.62 (7.32%)

43.44 (-38.33%)

Price to Book Ratio (P/B)

4.41 (-42.96%)

7.74 (29.20%)

5.99 (61.73%)

3.7 (-29.93%)

Debt to Equity Ratio (D/E)

0.16 (-60.29%)

0.41 (70.71%)

0.24 (214.47%)

0.08 (2.70%)

Earnings Per Share (EPS)

-1.12 (17.04%)

-1.35 (2.17%)

-1.38 (8.00%)

-1.5 (-20.00%)

Sales Per Share (SPS)

0.3 (18.18%)

0.25 (8.12%)

0.23 (-9.65%)

0.26 (-11.30%)

Free Cash Flow Per Share (FCFPS)

-0.95 (9.29%)

-1.04 (15.53%)

-1.24 (-14.66%)

-1.08 (-2.86%)

Book Value Per Share (BVPS)

2.44 (67.24%)

1.46 (-41.43%)

2.49 (-35.83%)

3.88 (-21.73%)

Tangible Assets Book Value Per Share (TABVPS)

2.83 (39.03%)

2.03 (-33.44%)

3.05 (-23.27%)

3.98 (-21.93%)

Enterprise Value Over EBIT (EV/EBIT)

-9 (-50.00%)

-6 (53.85%)

-13 (-85.71%)

-7 (63.16%)

Enterprise Value Over EBITDA (EV/EBITDA)

-9.11 (-35.81%)

-6.71 (53.58%)

-14.45 (-80.93%)

-7.99 (60.72%)

Asset Turnover

0.19 (42.65%)

0.14 (43.16%)

0.1 (30.14%)

0.07 (-1.35%)

Current Ratio

10.52 (59.85%)

6.58 (-55.60%)

14.82 (-20.15%)

18.56 (-8.67%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$23,453,000 (-5.18%)

-$22,297,000 (13.58%)

-$25,800,000 (-15.22%)

-$22,392,000 (-8.84%)

Enterprise Value (EV)

$170,068,596 (4.48%)

$162,781,934 (-16.27%)

$194,414,387 (10.36%)

$176,170,947 (-45.11%)

Earnings Before Tax (EBT)

-$27,818,000 (16.97%)

-$33,503,000 (-105.65%)

-$16,291,000 (46.44%)

-$30,415,000 (-24.76%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$26,882,000 (16.71%)

-$32,276,000 (-75.12%)

-$18,431,000 (34.72%)

-$28,233,000 (-40.27%)

Invested Capital

$13,617,000 (-27.50%)

$18,783,000 (-11.69%)

$21,269,000 (67.20%)

$12,721,000 (-1.99%)

Working Capital

$62,500,000 (75.91%)

$35,530,000 (-38.57%)

$57,839,000 (-20.74%)

$72,970,000 (-21.48%)

Tangible Asset Value

$69,973,000 (61.15%)

$43,421,000 (-31.88%)

$63,741,000 (-22.88%)

$82,651,000 (-17.37%)

Market Capitalization

$185,209,900 (2.10%)

$181,395,073 (-20.21%)

$227,339,934 (-2.53%)

$233,238,689 (-42.20%)

Average Equity

$44,145,750 (8.44%)

$40,710,250 (-36.01%)

$63,617,000 (-27.70%)

$87,986,250 (-3.98%)

Average Assets

$54,970,750 (3.52%)

$53,100,750 (-24.63%)

$70,451,000 (-25.04%)

$93,987,500 (-5.03%)

Invested Capital Average

$14,324,000 (-21.79%)

$18,315,250 (18.92%)

$15,401,000 (7.87%)

$14,278,000 (11.42%)

Shares

24,661,771 (15.43%)

21,365,733 (2.35%)

20,876,027 (0.51%)

20,769,251 (5.83%)